Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration

Toxicology and Applied Pharmacology
L E SolemK B Wallace

Abstract

Doxorubicin (Adriamycin) is an anthracycline antibiotic with broad antineoplastic activity. However, the clinical success is limited by the incidence of cumulative cardiomyopathy. In vitro, doxorubicin elicits a cyclosporine A-sensitive release of calcium from cardiac mitochondria. It has been suggested that this leads to mitochondrial calcium cycling and depolarization of membrane potential, which may account for the inhibition of mitochondrial respiration and cytotoxicity observed with the drug. Implication of a similar mechanism in the manifestation of clinical doxorubicin toxicity requires evidence for a disruption of mitochondrial calcium homeostasis following chronic in vivo administration. Cardiac mitochondria isolated from doxorubicin-treated rats (2 mg/kg/week, s.c. x 13 weeks) had a lower RCR but no change in ADP/O compared to controls and exhibited an enhanced cyclosporine A-sensitive release of mitochondrial calcium. Associated with this was a calcium-induced depolarization of membrane potential, which was inhibited by either cyclosporine A or ruthenium red suggesting the induction of mitochondrial calcium cycling following chronic doxorubicin treatment. The persistence of these effects on mitochondrial calcium regu...Continue Reading

Citations

Mar 8, 2008·Expert Opinion on Drug Safety·Vilma A SardãoPaulo J Oliveira
Feb 15, 2011·Drug and Chemical Toxicology·Nurcan DursunLeyla Sahin
Jan 1, 1996·Archives of Physiology and Biochemistry·V I KapelkoJ P Morgan
Aug 29, 2012·Journal of Pharmacological and Toxicological Methods·Fabio CerignoliMark Mercola
Jan 13, 2010·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jian-Yong Qian, Liang Guo
Nov 26, 2015·Journal of Pharmaceutical and Biomedical Analysis·Qian-Yun NiuXue-Mei Qin
Nov 9, 2007·Toxicology·Roohollah Babaei KelishomiAhmad Reza Dehpour
Sep 13, 2003·Pharmacology & Toxicology·Kendall B Wallace
Mar 19, 2016·The Journal of Pharmacy and Pharmacology·Ann-Marie Meredith, Crispin R Dass
Oct 7, 2006·Free Radical Biology & Medicine·Yumin ChenDaret K St Clair
Aug 2, 2006·Journal of Molecular and Cellular Cardiology·Malgorzata Tokarska-SchlattnerUwe Schlattner
Sep 2, 2006·Comptes rendus biologies·Malgorzata Tokarska-SchlattnerUwe Schlattner
Sep 11, 2013·Free Radical Biology & Medicine·Laura A A GilliamP Darrell Neufer
Oct 17, 1998·Toxicology and Applied Pharmacology·J B CustodioK B Wallace
Nov 29, 2008·Biochimica Et Biophysica Acta·Nicole M DiotteYe-Shih Ho
Jun 4, 2011·International Journal of Cardiology·António AscensãoJosé Magalhães
Feb 4, 2014·Journal of Molecular and Cellular Cardiology·Ioanna AndreadouEfstathios K Iliodromitis
Jul 11, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·H E MohamedH H Hagar
Jan 26, 2010·Toxicology and Applied Pharmacology·David MontaigneRemi Neviere
Oct 19, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mirela EnacheMadalin Iancu Enache
Oct 13, 2004·Toxicology and Applied Pharmacology·Paulo J OliveiraKendall B Wallace
Dec 11, 2007·International Journal of Toxicology·D A Rendon
Jul 1, 1996·Toxicologic Pathology·P Della TorreG Mazué
May 11, 2001·Cancer Chemotherapy and Pharmacology·P Della TorreM Brughera
Sep 30, 2006·Cell Biology and Toxicology·J M Berthiaume, K B Wallace
Jul 27, 2007·Cardiovascular Toxicology·Kendall B Wallace
Jan 24, 2014·American Journal of Therapeutics·J Rick TurnerSnehal Kothari
Jun 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wei ShiGuozhen Cui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Biochemical and Biophysical Research Communications
L C Trost, K B Wallace
Biochemical and Biophysical Research Communications
L C Trost, K B Wallace
Canadian Journal of Physiology and Pharmacology
Libuše ZatloukalováRadomír Hrdina
© 2021 Meta ULC. All rights reserved